LY 3200882
目录号: A16816
TGFβRI 抑制剂
LY 3200882 是一种强效的、高度选择性的 TGF-β 受体类型 1 (TGFβRI) 抑制剂。它在体外的肿瘤和免疫细胞中以及体内的皮下肿瘤中,都能强效抑制 TGFβ 介导的 SMAD 磷酸化,并且这种抑制作用是剂量依赖性的。
Discription | LY 3200882 is a potent, highly selective inhibitor of TGF-β receptor type 1 (TGFβRI). It potently inhibits TGFβ mediated SMAD phosphorylation in vitro in tumor and immune cells and in vivo in subcutaneous tumors in a dose dependent fashion. |
---|
目录号 | A16816 |
---|---|
分子式 | C24H29N5O3 |
分子量 | 435.52 |
CAS号 | 1898283-02-7 |
SMILES | CC(O)(C)C1=NC=CC(NC2=NC=CC(OC3=CN(C4CC4)N=C3C5CCOCC5)=C2)=C1 |
其他名称 | LY-3200882, LY3200882 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 79 mg/mL (181.39 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.96 mL | 114.81 mL | 229.61 mL |
0.5 mM | 4.59 mL | 22.96 mL | 45.92 mL |
1 mM | 2.3 mL | 11.48 mL | 22.96 mL |
5 mM | 0.46 mL | 2.3 mL | 4.59 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2